Risk factor
High price volatility
Profitability factor
Undervalued vs peers
About
Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, und
Target Price
The average target price of CLARI.PA is 4.72 and suggests 16.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to